Second malignant neoplasms in patients with non hodgkin's lymphoma
β Scribed by Dr Michael Lishner; Joyce Slingerland; Joseph Barr; Tony Panzarella; Pam Degendorfer; Simon Sutcliffe
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 715 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A retrospective review of the records of 3886 patients with nonβHodgkin's lymphoma registered at the Princess Margaret Hospital between 1970 and 1985 was undertaken to determine the incidence of second malignant tumours. Three thousand and twentyβone patients with a minimum documented followβup of 6 months from referral were identified for analysis. The overall observed/expected ratio for all cancers in patients with malignant lymphoma was 1, suggesting no increased risk of developing a second malignant neoplasm compared to the general population. When the data were analyzed independently for each tumour site, statistically significant increased risk of developing acute non lymphocytic leukemia (ANLL) (p < 0Β·001) and carcinoma of the tongue (p < 0Β·05) were found. An increased risk of lung cancer following lymphoma was detected but was not statistically significant. Survival following diagnosis of ANLL and lung cancer was similar and significantly shorter than that following the diagnosis of other second malignancies. The risk of developing a second primary cancer was significantly related to increasing patient age.
π SIMILAR VOLUMES
The incidence of second malignant neoplasms (SMN's) was investigated in a group of 529 patients with Hodgkin's Disease(HD) treated at St Bartholomew's Hospital (SBH). SMNs were seen in 27 of these patients giving an incidence rate three and a half times that expected in an age and sex matched normal
The causes of death and postmortem findings in patients treated for non-Hodgkin's lymphoma at a single institution over a 13-year period were reviewed. Postmortem examination (70% of the entire sample) revealed evidence of lymphoma in 67 of 80 patients. The most frequent extranodal sites of involvem